23.14
price up icon0.39%   0.09
after-market アフターアワーズ: 22.88 -0.26 -1.12%
loading
前日終値:
$23.05
開ける:
$22.43
24時間の取引高:
3.05M
Relative Volume:
1.20
時価総額:
$2.96B
収益:
$631.73M
当期純損益:
$-239.78M
株価収益率:
-11.46
EPS:
-2.02
ネットキャッシュフロー:
$-33.45M
1週間 パフォーマンス:
+22.50%
1か月 パフォーマンス:
+15.99%
6か月 パフォーマンス:
+73.07%
1年 パフォーマンス:
+116.46%
1日の値動き範囲:
Value
$21.83
$23.26
1週間の範囲:
Value
$18.52
$23.26
52週間の値動き範囲:
Value
$6.78
$23.56

10 X Genomics Inc Stock (TXG) Company Profile

Name
名前
10 X Genomics Inc
Name
セクター
Healthcare (1110)
Name
電話
(925) 401-7300
Name
住所
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
Name
職員
1,178
Name
Twitter
@10xgenomics
Name
次回の収益日
2024-10-31
Name
最新のSEC提出書
Name
TXG's Discussions on Twitter

Compare TXG vs VEEV, TEM, BTSG, HQY, WAY

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Health Information Services icon
TXG
10 X Genomics Inc
23.14 2.94B 631.73M -239.78M -33.45M -2.02
Health Information Services icon
VEEV
Veeva Systems Inc
181.45 29.92B 3.08B 860.33M 1.35B 5.1463
Health Information Services icon
TEM
Tempus Ai Inc
53.31 9.52B 803.32M -709.10M -212.68M -7.8003
Health Information Services icon
BTSG
Brightspring Health Services Inc
41.58 7.47B 11.99B 24.18M 234.31M 0.2956
Health Information Services icon
HQY
Healthequity Inc
77.93 6.54B 1.15B 96.70M -161.99M 1.09
Health Information Services icon
WAY
Waystar Holding Corp
26.25 4.92B 906.14M -52.62M 89.62M -0.3621

10 X Genomics Inc Stock (TXG) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-12-11 ダウングレード Citigroup Buy → Neutral
2025-12-02 ダウングレード Morgan Stanley Overweight → Equal-Weight
2025-09-11 開始されました Piper Sandler Neutral
2025-02-13 ダウングレード Leerink Partners Outperform → Market Perform
2024-09-03 開始されました Leerink Partners Outperform
2024-07-22 アップグレード Jefferies Hold → Buy
2024-07-18 ダウングレード JP Morgan Overweight → Neutral
2024-07-10 ダウングレード Deutsche Bank Buy → Hold
2024-06-27 ダウングレード Wolfe Research Outperform → Peer Perform
2024-06-25 ダウングレード Guggenheim Buy → Neutral
2024-06-03 再開されました Jefferies Hold
2024-05-01 ダウングレード TD Cowen Buy → Hold
2023-12-14 開始されました Guggenheim Buy
2023-12-13 開始されました Wolfe Research Outperform
2023-12-12 アップグレード BofA Securities Underperform → Neutral
2023-07-05 再開されました JP Morgan Overweight
2023-05-10 開始されました Barclays Overweight
2023-03-31 開始されました Stephens Overweight
2023-02-02 開始されました UBS Neutral
2022-12-14 開始されました Deutsche Bank Buy
2022-08-18 ダウングレード Goldman Neutral → Sell
2022-07-25 開始されました Canaccord Genuity Buy
2022-07-15 ダウングレード BofA Securities Neutral → Underperform
2022-07-15 ダウングレード William Blair Outperform → Mkt Perform
2021-10-15 再開されました Cowen Outperform
2021-09-14 ダウングレード BofA Securities Buy → Neutral
2021-03-15 開始されました William Blair Outperform
2020-12-02 開始されました Goldman Neutral
2020-09-09 開始されました Morgan Stanley Overweight
2020-07-10 開始されました Stifel Buy
2020-03-05 開始されました Guggenheim Buy
2020-01-07 開始されました Citigroup Buy
2019-10-07 開始されました BofA/Merrill Buy
2019-10-07 開始されました Cowen Outperform
2019-10-07 開始されました JP Morgan Overweight
2019-09-24 開始されました Evercore ISI Outperform
すべてを表示

10 X Genomics Inc (TXG) 最新ニュース

pulisher
Feb 21, 2026

Is 10x Genomics Inc. (1KJ) stock positioned for secular growthRecession Risk & Expert Curated Trade Ideas - mfd.ru

Feb 21, 2026
pulisher
Feb 20, 2026

TXG: UBS Raises Price Target for 10x Genomics to $20 | TXG Stock News - GuruFocus

Feb 20, 2026
pulisher
Feb 19, 2026

10x Genomics to Participate in the 46th Annual TD Cowen Health Care Conference - BioSpace

Feb 19, 2026
pulisher
Feb 19, 2026

5 Must-Read Analyst Questions From 10x Genomics's Q4 Earnings Call - Finviz

Feb 19, 2026
pulisher
Feb 18, 2026

GSA Capital Partners LLP Buys 106,167 Shares of 10x Genomics $TXG - MarketBeat

Feb 18, 2026
pulisher
Feb 18, 2026

162,202 Shares in 10x Genomics $TXG Bought by Principal Financial Group Inc. - MarketBeat

Feb 18, 2026
pulisher
Feb 15, 2026

10x Genomics Stock Climbs as Analysts Signal Growth Prospects - StocksToTrade

Feb 15, 2026
pulisher
Feb 15, 2026

10x Genomics’ Growth Prospects Brightened by Strategic Advances - timothysykes.com

Feb 15, 2026
pulisher
Feb 14, 2026

10x Genomics Cancer Alliances Test AI Ambitions Against Mixed Share Performance - Yahoo Finance

Feb 14, 2026
pulisher
Feb 14, 2026

10x Genomics Sees Bullish Momentum Following Revenue Projections and Price Target Upgrades - StocksToTrade

Feb 14, 2026
pulisher
Feb 14, 2026

10x Genomics Sees Bullish Momentum with Raised Price Targets - timothysykes.com

Feb 14, 2026
pulisher
Feb 14, 2026

Is 10x Genomics Inc. still a buy after recent gains2025 Biggest Moves & AI Forecast Swing Trade Picks - mfd.ru

Feb 14, 2026
pulisher
Feb 14, 2026

Decoding 10x Genomics Inc (TXG): A Strategic SWOT Insight - GuruFocus

Feb 14, 2026
pulisher
Feb 14, 2026

Earnings Call Summary | 10x Genomics(TXG.US) Q4 2025 Earnings Conference - 富途牛牛

Feb 14, 2026
pulisher
Feb 13, 2026

Expert Outlook: 10x Genomics Through The Eyes Of 10 Analysts - Benzinga

Feb 13, 2026
pulisher
Feb 13, 2026

10X Genomics stock price target raised to $22 from $20 at Canaccord Genuity - Investing.com UK

Feb 13, 2026
pulisher
Feb 13, 2026

Why Is 10x Genomics (TXG) Stock Soaring Today - Finviz

Feb 13, 2026
pulisher
Feb 13, 2026

10X Genomics stock price target raised to $22 from $20 at Canaccord Genuity By Investing.com - Investing.com India

Feb 13, 2026
pulisher
Feb 13, 2026

10x Genomics (NASDAQ:TXG) Shares Gap Up on Earnings Beat - MarketBeat

Feb 13, 2026
pulisher
Feb 13, 2026

10x Genomics, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance

Feb 13, 2026
pulisher
Feb 13, 2026

10x Genomics, Inc. (NASDAQ:TXG) Q4 2025 Earnings Call Transcript - Insider Monkey

Feb 13, 2026
pulisher
Feb 13, 2026

10x Genomics Q4 Earnings Call Highlights - MarketBeat

Feb 13, 2026
pulisher
Feb 13, 2026

10x Genomics, Inc. SEC 10-K Report - TradingView

Feb 13, 2026
pulisher
Feb 13, 2026

10x Genomics: Fourth Quarter Financial Overview - Bitget

Feb 13, 2026
pulisher
Feb 13, 2026

10x Genomics Inc (TXG) Q4 2025 Earnings Call Highlights: Surpass - GuruFocus

Feb 13, 2026
pulisher
Feb 12, 2026

Can 10x Genomics Inc. stock outperform in a bear market2025 Top Decliners & High Return Trade Opportunity Guides - mfd.ru

Feb 12, 2026
pulisher
Feb 12, 2026

10x Genomics (TXG) Q4 2025 Earnings Transcript - AOL.com

Feb 12, 2026
pulisher
Feb 12, 2026

10x Genomics (TXG) Surpasses Q4 Revenue Expectations - GuruFocus

Feb 12, 2026
pulisher
Feb 12, 2026

Compared to Estimates, 10x Genomics (TXG) Q4 Earnings: A Look at Key Metrics - Yahoo Finance

Feb 12, 2026
pulisher
Feb 12, 2026

Earnings call transcript: 10x Genomics beats Q4 2025 EPS forecast By Investing.com - Investing.com India

Feb 12, 2026
pulisher
Feb 12, 2026

Earnings call transcript: 10x Genomics beats Q4 2025 EPS forecast - Investing.com

Feb 12, 2026
pulisher
Feb 12, 2026

10x Genomics (NASDAQ:TXG) Delivers Impressive Q4 CY2025 - Finviz

Feb 12, 2026
pulisher
Feb 12, 2026

10x Genomics (TXG) Reports Q4 Loss, Beats Revenue Estimates - Yahoo Finance

Feb 12, 2026
pulisher
Feb 12, 2026

10x Genomics Q4 2025 Financial Results: Loss Narrows, Revenue at $166MNews and Statistics - IndexBox

Feb 12, 2026
pulisher
Feb 12, 2026

10x Genomics Q4 Loss Narrows, Revenue Rises; 2026 Guidance Set - marketscreener.com

Feb 12, 2026
pulisher
Feb 12, 2026

10x Genomics (NASDAQ:TXG) Releases Quarterly Earnings Results, Beats Estimates By $0.06 EPS - MarketBeat

Feb 12, 2026
pulisher
Feb 12, 2026

10x Genomics: Q4 Earnings Snapshot - kare11.com

Feb 12, 2026
pulisher
Feb 12, 2026

Earnings Flash (TXG) 10x Genomics, Inc. Reports Q4 Revenue $166.0M, vs. FactSet Est of $159.7M - marketscreener.com

Feb 12, 2026
pulisher
Feb 12, 2026

10x Genomics Earnings Report: Q4 Overview - Benzinga

Feb 12, 2026
pulisher
Feb 12, 2026

10x Genomics (NASDAQ: TXG) narrows 2025 losses and guides to modest 2026 growth - Stock Titan

Feb 12, 2026
pulisher
Feb 12, 2026

10x Genomics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Outlook for 2026 - PR Newswire

Feb 12, 2026
pulisher
Feb 12, 2026

10X Genomics faces earnings test as new pricing strategy debuts By Investing.com - Investing.com South Africa

Feb 12, 2026
pulisher
Feb 12, 2026

10X Genomics faces earnings test as new pricing strategy debuts - Investing.com

Feb 12, 2026
pulisher
Feb 12, 2026

10x Genomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026 - Finansavisen

Feb 12, 2026
pulisher
Feb 11, 2026

What makes 10x Genomics Inc. stock attractive todayQuarterly Profit Report & Free Community Consensus Stock Picks - mfd.ru

Feb 11, 2026
pulisher
Feb 11, 2026

10x Genomics Earnings Preview - Sahm

Feb 11, 2026
pulisher
Feb 10, 2026

10x Genomics Earnings Preview: Revenue Forecast, Analyst Estimates & Stock OutlookNews and Statistics - IndexBox

Feb 10, 2026
pulisher
Feb 10, 2026

10x Genomics (TXG) Reports Earnings Tomorrow: What To Expect - Finviz

Feb 10, 2026
pulisher
Feb 09, 2026

10x Genomics gets injunction against Parse Biosciences' ATAC Products - MSN

Feb 09, 2026
pulisher
Feb 08, 2026

10x Genomics Expands Flex Lineup with High-Throughput Single-Cell Assay Launch - MSN

Feb 08, 2026
pulisher
Feb 06, 2026

IQ EQ FUND MANAGEMENT IRELAND Ltd Buys 190,059 Shares of 10x Genomics $TXG - MarketBeat

Feb 06, 2026

10 X Genomics Inc (TXG) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$24.04
price up icon 1.22%
$44.86
price up icon 4.91%
$24.05
price up icon 3.84%
$25.70
price up icon 4.77%
health_information_services WAY
$26.25
price up icon 2.34%
大文字化:     |  ボリューム (24 時間):